Gender features of chronic heart failure, the optimization of medication therapy and diagnostics

23 May 2016 (08:30 - 18:00)

Organised by:

About the speaker

Doctor Gulnaz Dadashova

Scientific Research Institute of Cardiology, Baku (Azerbaijan)

22 More presentations in this session

Presentation thumbnail

Zofenopril combined with xanthine oxidase inhibitors may improve survival in post-myocardial infarction patients as compared to placebo or other ACE-inhibitors

Presentation thumbnail

Long-term effects and sustainability of collaborative disease management in systolic heart failure - the extended interdisciplinary network heart failure study

Professor C. Angermann (Wurzburg, DE)

Presentation thumbnail

An implantable pressure sensor for long-term wireless monitoring of cardiac function -first study in man

Doctor J. Baranowski (Linkoping, SE)

Presentation thumbnail

Heart failure hospitalisation or cardiovascular death with empagliflozin in patients with type 2 diabetes and high cardiovascular risk: analysis over time in EMPA-REG OUTCOME

Doctor D. Fitchett (Toronto, CA)

Presentation thumbnail

Long-term safety and efficacy of sodium zirconium cyclosilicate (ZS-9) in the treatment of hyperkalaemia: interim analysis of ZS-005, an open-label phase 3 study

Professor S. Anker (Berlin, DE)

Access the full session

Session thumbnail

Clinical Forum - Mon. 23 May 08:30 - Tues. 24 May 12:30

The Event

HEART FAILURE 2016

23 May 2016 08:30 CET

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources